Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0000905718-20-000734)

Filing Details

Accession Number:: 0000905718-20-000734
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-07-07 16:53:14
Reporting Period:: 2020-07-07

Accepted Time:: 2020-07-07 16:53:14
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1684144	Zomedica Pharmaceuticals Corp.	ZOM	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1134545	D Johnny Powers	C/O Zomedica Pharmaceuticals Corp. 100 Phoenix Drive, Suite 180 Ann Arbor MI 48108		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Without Par Value	Acquisiton	2020-07-07	625,000	$0.16	625,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock, Without Par Value	Warrant	Acquisiton	2020-07-07	625,000	$0.00	625,000	$0.16

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
625,000	2020-07-07	2022-07-07	No	4	P	Direct

Footnotes

Securities were issued pursuant to an underwritten public offering. Each share of common stock was sold together with one Series D warrant to purchase one share of common stock.